News
Bart Vanhaesebroeck, bridging gaps between basic and translational research
The professor of the Barts Cancer Institute of London, Bart Vanhaesebroeck, offered last October 11, in the frame of the IDIBELL Seminars, a summary of his research on the signaling of the PI3 Kinase. Dr. Vanhaesebroeck stressed that he has spent 20 years researching in the field of PI3K, where he began by cloning one […]
Alterations in DICER protein promote metastasis in colon cancer
MicroRNAs Stem cells control the growth and development of tumor metastasis Article’s reference Impaired DICER1 function promotes stemness and metastasis in colon cancer
Manel Esteller, corresponding academic of the Royal Academy of Medicine of Valencia
The researcher Manel Esteller, director of the Epigenetics and Cancer Biology IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor was elected Corresponding Academic of the Royal Academy of Medicine of Valencia (RAMCV). The appointment wants to recognize the scientific career of Manel Esteller in the field of epigenetics and its […]
IDIBELL’s researchers discover a potential therapeutic target to slow the growth of tumors
A study by the Bellvitge Institute of Biomedical Research (IDIBELL ) led by the head of the research group in signaling pathways in angiogenesis , Mariona Graupera concludes that p110alpha protein inhibition in mice causes a reduction of tumor growth associated with a defect in blood vessel formation . Study results were published in the […]
Researchers discover the genetic signature of highly aggressive small lung tumours
Lung cancer is currently the most lethal in the world. The main cause of these tumors is the tobacco and it is usually diagnosed in advanced stages when there are already few treatment options. There is a subgroup of tumors of the lung that thanks to diagnostic advances can be detected in early stages and […]
Scientists of the IDIBELL explain the rare diseases to citizens
On September 27 took place the Researchers’ Night at the Cosmo Caixa of Barcelona with the active participation of 6 scientists of the IDIBELL. On the occasion of the year of the rare diseases, the Researchers’ Night in Barcelona focused on these diseases that have 400,000 affected throughout Catalonia.Virginia Nunes, Dori Huertas, Ethel Queralt and […]
TRANSLINK, the European project to develop treatments that prevent immune responses against biological cardiac prostheses
Translink is a project that will have a duration of four years and a budget of 7.8 M € , co-financed by the European Union under the 7th Framework Programme. Dr. Rafael Máñez , director of the project in 2 hospitals of the ICS (Catalan Health Institute , stresses that this project will apply the […]